...
首页> 外文期刊>Kidney international. >Glomerular filtration rate estimated by cystatin C among different clinical presentations
【24h】

Glomerular filtration rate estimated by cystatin C among different clinical presentations

机译:不同临床表现中胱抑素C估计的肾小球滤过率

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Glomerular filtration rate (GFR) estimates from serum creatinine has not been generalizable across all populations. Cystatin C has been proposed as an alternative marker for estimating GFR. The objective of this study was to compare cystatin C with serum creatinine for estimating GFR among different clinical presentations. Cystatin C and serum creatinine levels were obtained from adult patients (n=460) during an evaluation that included a GFR measurement by iothalamate clearance. Medical records were abstracted for clinical presentation (healthy, native chronic kidney disease or transplant recipient) at the time of GFR measurement. GFR was modeled using the following variables: cystatin C (or serum creatinine), age, gender and clinical presentation. The relationship between cystatin C and GFR differed across clinical presentations. At the same cystatin C level, GFR was 19% higher in transplant recipients than in patients with native kidney disease (PPn=204). The correlation with GFR (r2=0.853) was slightly higher than a serum creatinine equation using the same sample (r2=0.827), the Modification of Diet in Renal Disease equation (r2=0.825) or the Cockcroft–Gault equation (r2=0.796). Averaged estimates between cystatin C and serum creatinine equations further improved correlation (r2=0.891). Cystatin C should not be interpreted as purely a marker of GFR. Other factors, possibly inflammation or immunosuppression therapy, affect cystatin C levels. While recognizing this limitation, cystatin C may improve GFR estimates in chronic kidney disease patients.
机译:血清肌酐估计肾小球滤过率(GFR)尚未在所有人群中推广。胱抑素C已被提议作为估计GFR的替代标记。这项研究的目的是比较半胱氨酸蛋白酶抑制剂C与血清肌酐在不同临床表现之间的GFR估算。评估过程中从成年患者(n = 460)获得了胱抑素C和血清肌酐水平,该评估包括通过碘乙酸酯清除率进行的GFR测量。在进行GFR测量时,会提取医学记录以进行临床表现(健康的,自然的慢性肾脏疾病或移植受者)。 GFR使用以下变量建模:胱抑素C(或血清肌酐),年龄,性别和临床表现。胱抑素C和GFR之间的关系在临床表现中有所不同。在相同的半胱氨酸蛋白酶抑制剂C水平下,移植受体的GFR比天然肾脏疾病患者高19%(PPn = 204)。与GFR的相关性(r2 = 0.853)略高于使用相同样品的血清肌酐方程式(r2 = 0.827),肾脏疾病饮食的饮食调整方程式(r2 = 0.825)或Cockcroft-Gault方程式(r2 = 0.796) )。胱抑素C和血清肌酐方程之间的平均估计值进一步改善了相关性(r2 = 0.891)。胱抑素C不应仅被解释为GFR的标志物。其他因素,可能是炎症或免疫抑制疗法,会影响胱抑素C的水平。尽管认识到这一限制,但胱抑素C可能会改善慢性肾脏病患者的GFR估计值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号